Kevin Leach
Corporate Officer/Principal chez Massachusetts Institute of Technology
Profil
Kevin Leach currently works at Massachusetts Institute of Technology, as Member.
Dr. Leach also formerly worked at Travere Therapeutics, Inc., as Senior Director-Translational Research and F-Star Therapeutics, Inc. (United States), as VP-Nonclinical & Translational Research.
Dr. Leach received his undergraduate degree from the University of Richmond.
Postes actifs de Kevin Leach
| Sociétés | Poste | Début |
|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Anciens postes connus de Kevin Leach
| Sociétés | Poste | Fin |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| SPRING BANK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Kevin Leach
| University of Richmond | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
